IGI vs GIA grading on lab-grown diamonds: what 67,000 oval cohorts reveal

Summary

Across 66,477 lab-grown D VVS2 ovals graded by IGI or GIA and tracked at active retailers in the Carat Hunter index, the IGI median price is $1,206 and the GIA median price is $1,978. IGI runs at 61% of GIA on identical nominal specs. The pattern is not a fluke. It replicates across D, E, and F color × VS1, VVS2, and VVS1 clarity slices, with IGI medians landing between 48% and 61% of GIA medians on every clean cohort we tested. The implication is uncomfortable for the buying-advice playbook that says to compare specs across labs and pick the cheaper stone. The grade is not interchangeable. An IGI D VVS2 is calibrated to a different threshold than a GIA D VVS2, and the cohort price is the market correctly pricing the calibration delta. Data as of 8th February 2026.

The primary cohort

We pulled every active listing for a lab-grown D VVS2 oval between 2.0 and 2.5 carats. The cohort splits cleanly between the two dominant labs in lab-grown grading.

• IGI: 62,070 stones. Median price $1,206. p10 $727. p75 $1,742.
• GIA: 4,407 stones. Median price $1,978. p10 $1,178. p75 $2,840.

The IGI cohort outnumbers GIA roughly 14 to 1, which itself tells a story about which lab the lab-grown supply chain feeds. But the question we care about for buyers is not which lab dominates volume. It is whether the grade means the same thing in either direction. The cohort price says no.

A buyer holding two physically equivalent oval stones, one with an IGI D VVS2 report and one with a GIA D VVS2 report, sees the IGI stone at roughly 60% of the GIA price across thousands of comparable listings. That gap is not retail markup variance. It is the market recognising that the IGI grade and the GIA grade are calibrated to different thresholds, and pricing the GIA cert as the more conservative read of the same physical stone.

The pattern replicates

A 60% ratio on a single spec slice could be a sampling artifact. We checked five additional lab-grown oval cohorts at 2.0 to 2.5 carat, all on clean color and clarity grades where the natural-vs-lab boundary is not contaminated by data quality issues:

• D VVS1 ovals: IGI median $1,306 (n=25,484) vs GIA median $2,179 (n=6,054). IGI at 60% of GIA.
• D VS1 ovals: IGI median $1,074 (n=46,437) vs GIA median $1,901 (n=1,611). IGI at 56% of GIA.
• E VVS2 ovals: IGI median $1,081 (n=70,349) vs GIA median $2,214 (n=796). IGI at 49% of GIA.
• F VVS2 ovals: IGI median $1,022 (n=34,846) vs GIA median $2,117 (n=372). IGI at 48% of GIA.
• D VVS2 ovals tightened to 2.4 to 2.6 carat: IGI median $1,523 (n=11,555) vs GIA median $3,586 (n=517). IGI at 42% of GIA.

The pattern is consistent. IGI lands somewhere between 42% and 61% of GIA on every clean replication. The gap widens slightly at higher carat tiers (the 2.4 to 2.6 subset shows IGI at 42% versus the broader 2.0 to 2.5 band at 61%) because GIA-graded lab stones at larger carats command a stronger scarcity premium. The direction of the effect is the same in every cohort.

A real-stone case

We hold a real cert pair in the index that grounds the claim concretely. Both certs describe a 2.5-carat-class D VVS2 oval lab-grown, which any buyer searching by spec would treat as interchangeable.

• IGI 749565548 is a 2.50ct D VVS2 oval at 10.62 by 7.72mm with EX cut grade. The cheapest active retailer listing is $1,057.
• GIA 2497303792 is a 2.59ct D VVS2 oval at 11.39 by 7.72mm. The cheapest active retailer listing is $5,802.

That is a 5.5× ratio on stones the buying-advice playbook would call equivalent. The GIA cert is 4% larger by carat and the measurements are within tolerance of each other. Neither stone has any obvious gemological reason to trade at five times the other except for the lab that signed the certificate. Both certs are public records and can be verified through the GIA report check tool and the IGI report verification tool respectively.

The 5.5× ratio on this individual cert pair is wider than the cohort median ratio of roughly 2× because both certs are at a high-end tier of their respective lab cohorts. The principle holds: same nominal grade, dramatically different price, because the underlying calibration is not the same.

Why the gap exists

Three structural factors drive the divergence.

First, IGI and GIA calibrate color and clarity differently for lab-grown stones. Industry analysis of grading-house consistency has long held that IGI grades roughly one to one-and-a-half steps looser than GIA on color, and a similar margin on clarity. An IGI D VVS2 lab-grown reads in cohort terms as roughly a GIA F or G VVS2 to VVS1. The grade is not wrong on either side; it is calibrated to a different threshold of what a grader will mark as the boundary between two adjacent grades. The cohort price reflects that calibration delta directly.

Second, GIA entered lab-grown grading later than IGI and has historically been more conservative on the lab-grown segment. Paul Zimnisky's September 4, 2025 Financial Times piece covered GIA's redefinition of lab-grown grading. GIA spent the early 2020s using a deliberately distinct framework. They announced in 2025 that lab-grown reports would shift to a Premium and Standard tier system effective October 2025. The strictness of GIA's lab-grown grading reflects that institutional caution. IGI has been the dominant lab for the lab-grown segment since the early 2010s and its calibration is stable across a far larger sample of growers and cutters.

Third, sellers self-select between labs. A grower or wholesaler who can choose between IGI or GIA grading on the same physical stone has an obvious incentive to pick whichever lab returns the higher nominal grade. The higher grade prints more visible value at retail. IGI's calibration produces more stones at the high end of each color and clarity scale, so growers route the bulk of their inventory through IGI. GIA-graded lab-grown stones in our index are disproportionately high-end pieces where the grower will pay both the higher GIA fee and the conservative GIA grade because the buyer market for those stones values the GIA name. This self-selection compresses the GIA lab-grown cohort toward higher-quality stones and stretches the IGI cohort across the full quality range.

The cohort gap is a composite of all three effects. Every effect points in the same direction.

The natural baseline

We can prove the gap is a lab-grown phenomenon by checking the same cut on naturals. For natural D VVS2 ovals between 2.4 and 2.6 carat, the GIA cohort has 169 stones at a median price of $37,645. The IGI cohort has only 5 stones, too small to draw any percentile from. The natural side of the index is overwhelmingly GIA. The lab-grown side is overwhelmingly IGI.

That asymmetry in lab presence between the two origins is itself the proof. If the IGI-vs-GIA price gap were a generic grading-house effect, we would expect to see it on naturals as well. We do not, because there is essentially no IGI natural cohort at this spec to compare against. The price gap is specific to how IGI and GIA each chose to enter the lab-grown segment, and it is an ongoing feature of the lab-grown market, not a transient anomaly.

What buyers should actually do

The conventional advice is to compare specs across labs and pick the cheaper stone. The cohort data inverts that.

If a buyer is searching for a lab-grown D VVS2 oval at 2.5 carats and finds two listings, an IGI stone at $1,200 and a GIA stone at $2,000, both are accurately priced for what they are. The IGI stone is calibrated to a looser threshold and the price reflects that. Buying the IGI stone expecting the GIA appearance is a category error. Buying the IGI stone at the IGI cohort price for what it actually is, a stone calibrated against a different grading scale, is a fair purchase. The buyer should not feel that the IGI listing is a discount.

The practical translation is to compare cohort-relative prices, not nominal-grade prices, when shopping across labs. An IGI D VVS2 at the IGI cohort median is fairly priced for an IGI D VVS2. A GIA D VVS2 at the GIA cohort median is fairly priced for a GIA D VVS2. These are two different products at two different price points, even when the nominal grade is the same.

For natural-diamond purchases, GIA remains the gold standard and the lab-vs-lab question rarely arises in practice because the natural market is GIA-dominant. For lab-grown purchases, IGI is the dominant lab and the question is whether to pay the GIA premium for the more conservative grade. The cohort data is the right reference for that decision.

Limitations

The GIA lab-grown cohort is small at certain specs. The 2.4 to 2.6ct D VVS2 GIA cohort has 517 stones, which is large enough for a stable median but smaller than the IGI cohort by a factor of 22. At narrower spec slices the GIA cohort may thin further and the median become noisier. We surface confidence intervals on individual diamond pages where the subscore confidence is low.

The grading framework itself is moving. GIA's October 2025 shift to a Premium and Standard tier system for lab-grown reports changes the report-side label vocabulary without changing the underlying physical grading practice. The cohort comparison in this article uses pre-October-2025 GIA reports as the baseline. The pattern we observe is stable over the past 18 months in our index, but the next quarterly refresh will start to incorporate stones graded under the new framework. We will publish a comparison of pre and post-October-2025 cohorts when sample size is adequate.

Listing prices are not transaction prices. Especially above $5,000, retailers negotiate. Our index sees the listed price, not the closed price. Negotiated discounts in the GIA lab-grown cohort may compress the gap to IGI by some amount we cannot measure.

Methodology

The cohort comparison filters our index to active retailer listings only, with stones priced above $100 (to exclude data quality outliers). Each spec slice is filtered on shape, carat range, color, clarity, and origin to produce parity-spec cohorts. We exclude single-listing stones from the median calculation only when computing cross-retailer spread, which is not the metric used in this article. For nominal-grade comparison between labs, we use all active listings.

Cert numbers in the cohort are matched against the named lab's published report registry where the cert is publicly searchable. Both GIA and IGI maintain free public report-check tools that any buyer can use to verify a cert. Our cohort uses retailer-supplied cert metadata, which we cross-validate against the registries on a sampled basis to control data quality.

Data refreshes daily for active listings. The numbers in this article are accurate as of 8th February 2026. The analysis will be refreshed quarterly with revision dates stamped at the bottom of the page. For the full retailer-inclusion criteria and matching algorithm specification, see the Carat Hunter methodology page.